Nanofiber Sheet for Rotator Cuff Healing with Localized rhPTH Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for rotator cuff tears, particularly postoperative healing failures, face challenges with high failure rates and complications from systemic recombinant parathyroid hormone (rhPTH) administration, necessitating a more effective and less invasive method for enhancing tendon-to-bone healing.
Innovation Solution
A nanofiber sheet containing recombinant parathyroid hormone (rhPTH) is developed for topical application, providing a localized delivery system that improves tendon-to-bone healing by enhancing vascular permeability, cell density, and collagen fiber orientation and maturation at the rotator cuff insertion site.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If systemic recombinant parathyroid hormone (rhPTH) is administered to improve tendon-to-bone healing, then healing effectiveness is improved, but complications and failure rates increase
Solution Approach 1:
The patent applies local quality by transitioning from systemic rhPTH administration to localized delivery at the rotator cuff insertion site. The nanofiber sheet is implanted directly at the tendon-to-bone interface, providing concentrated therapeutic effect precisely where needed while minimizing exposure to healthy tissues and reducing systemic complications.
Solution Approach 2:
The nanofiber sheet serves as an intermediary carrier that delivers rhPTH locally to the target site. This mediator enables controlled local release of the hormone, achieving therapeutic effects without the harmful side effects associated with systemic administration. The nanofiber matrix acts as a bridge between the drug and target tissue, enabling precise spatial and temporal control.
2Object-affected harmful factors
If direct topical rhPTH administration is used to reduce complications, then safety is improved, but healing effectiveness decreases
Solution Approach 1:
The patent employs composite materials by combining rhPTH with a nanofiber matrix (polycaprolactone, collagen, or gelatin). This composite structure allows the hormone to be delivered in a controlled manner, maintaining both safety through local delivery and effectiveness through sustained release. The nanofiber composite provides structural support while enabling drug delivery.
Solution Approach 2:
The nanofiber sheet enables periodic or sustained release of rhPTH over time, rather than a single bolus administration. This temporal control maintains therapeutic levels at the insertion site continuously, improving healing effectiveness while avoiding the peaks and valleys associated with intermittent dosing that can lead to complications.
3Object-affected harmful factors
If nanofiber sheet with rhPTH is used for localized delivery, then safety is improved, but device complexity increases
Solution Approach 1:
The patent uses thin film nanofiber sheets as the delivery system, which are flexible, conformable, and easy to implant. These thin film structures can be adapted to the curved surface of the rotator cuff insertion site, providing localized delivery without requiring complex rigid devices or multiple components. The simplicity of the thin film approach reduces surgical complexity while maintaining effective local delivery.
Data Source
AI summary
Provided is a nanofiber sheet for healing after rotator cuff repair containing recombinant parathyroid hormone and a method of manufacturing the same. The nanofiber sheet including a composition containing recombinant parathyroid hormone therein does not cause complications, and has an excellent effect of healing of rotator cuff tears by improving tendon to bone healing when the sheet is locally fixed or attached to a suture site, specifically rotator cuff tear site or rotator cuff suture site, compared to direct systemic or local administration of recombinant parathyroid hormone.